24
NPS Score
VS
Alnylam Pharmaceuticals
- EMPLOYEE
PARTICIPANTS - 23
- TOTAL
RATINGS
Flexion Therapeutics Claimed Company
- This companyis accepting feedback from verified employeesEMPLOYEE
PARTICIPANTS - 57
- TOTAL
RATINGS
Alnylam Pharmaceuticals vs Flexion Therapeutics
Compare Alnylam Pharmaceuticals versus Flexion Therapeutics for CEO Rating, Overall Culture Score, Brand Ranking, and other ratings. Results were generated by 23 employees and customers of Alnylam Pharmaceuticals and 57 employees and customers of Flexion Therapeutics.
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals's brand is ranked #- in the list of Global Top 1000 Brands, as rated by customers of Alnylam Pharmaceuticals. Their current market cap is $24.72B.
Flexion Therapeutics
Flexion Therapeutics's brand is ranked #- in the list of Global Top 1000 Brands, as rated by customers of Flexion Therapeutics. Flexion Therapeutics has a neutral social sentiment, when analyzing social media channels and online mentions. Their current market cap is $556.77M.
3.8/5
Product Quality
5/5
3/5
Pricing
4.5/5
3.3/5
Customer Service
4.5/5
| 62% | Promoters |
|---|---|
| 0% | Passive |
| 38% | Detractors |
100
NPS Score
| 100% | Promoters |
|---|---|
| 0% | Passive |
| 0% | Detractors |
Net Promoter Score
Winner by 76
See how Alnylam Pharmaceuticals compares to its competitors
See how Flexion Therapeutics compares to its competitors
Working at Alnylam Pharmaceuticals vs Working at Flexion Therapeutics
78 / 100
CEO Rating
98 / 100
CEO Rating
Winner by 20%
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals doesn't have enough ratings to calculate the Team Culture Ratings.
Know someone that works there? Invite them to rate their experience.
Flexion Therapeutics
Employees at Flexion Therapeutics rate their CEO, Mike Clayman, 98/100. This score is 20% higher than the scores of Alnylam Pharmaceuticals' CEO, John Maraganore. Employees in the Admin and IT departments rate Mike Clayman the highest.